Glenn Ramsey, Yara A Park, Anne F Eder, Aleh Bobr, Matthew S Karafin, Julie K Karp, Karen E King, Monica B Pagano, Joseph Schwartz, Zbigniew M Szczepiorkowski, Rhona J Souers, Lamont Thomas, Meghan Delaney
CONTEXT.—: Modern RHD genotyping can be used to determine when patients with serologic weak D phenotypes have RHD gene variants at risk for anti-D alloimmunization. However, serologic testing, RhD interpretations, and laboratory management of these patients are quite variable. OBJECTIVE.—: To obtain interlaboratory comparisons of serologic testing, RhD interpretations, Rh immune globulin (RhIG) management, fetomaternal hemorrhage testing, and RHD genotyping for weak D-reactive specimens...
May 2, 2021: Archives of Pathology & Laboratory Medicine